Last reviewed · How we verify
Silver nanoparticles mouthwash — Competitive Intelligence Brief
phase 3
Antimicrobial nanoparticle
Dentistry / Oral Health
Small molecule
Live · refreshed every 30 min
Target snapshot
Silver nanoparticles mouthwash (Silver nanoparticles mouthwash) — Can Tho University of Medicine and Pharmacy. Silver nanoparticles in mouthwash exert antimicrobial effects by disrupting bacterial cell membranes and inhibiting microbial growth in the oral cavity.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Silver nanoparticles mouthwash TARGET | Silver nanoparticles mouthwash | Can Tho University of Medicine and Pharmacy | phase 3 | Antimicrobial nanoparticle |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Antimicrobial nanoparticle class)
- Can Tho University of Medicine and Pharmacy · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Silver nanoparticles mouthwash CI watch — RSS
- Silver nanoparticles mouthwash CI watch — Atom
- Silver nanoparticles mouthwash CI watch — JSON
- Silver nanoparticles mouthwash alone — RSS
- Whole Antimicrobial nanoparticle class — RSS
Cite this brief
Drug Landscape (2026). Silver nanoparticles mouthwash — Competitive Intelligence Brief. https://druglandscape.com/ci/silver-nanoparticles-mouthwash. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab